Joe Petroziello

Joe Petroziello serves as Executive Vice President at MJH Life Sciences™ since April 2020 and holds a board member position at the Alliance for mRNA Medicines since October 2023, contributing to the advancement of mRNA therapeutics. Prior experience includes roles such as VP, Head of Corporate & Scientific Communications at Brainstorm Cell Therapeutics, and Head of Medical Writing & Medical Affairs at Juno Therapeutics, Inc. Additional roles in clinical affairs, business development, and medical writing span across companies like OncLive, HealthCare Alliance Group, and Parexel. Joe Petroziello's early career includes significant scientific contributions at Seagen and Sanofi Genzyme. Joe Petroziello holds a Master of Science in Chemistry and a Bachelor of Science in Biology, both from the University of Scranton.